- Home
- SBR vs LENZ Comparison
SBR vs LENZ Comparison
Compare SBR & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBR
- LENZ
- Stock Information
- Founded
- SBR 1982
- LENZ 2019
- Country
- SBR United States
- LENZ United States
- Employees
- SBR N/A
- LENZ N/A
- Industry
- SBR Oil & Gas Production
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- SBR Energy
- LENZ Health Care
- Exchange
- SBR Nasdaq
- LENZ Nasdaq
- Market Cap
- SBR 1.1B
- LENZ 1.1B
- IPO Year
- SBR N/A
- LENZ 2021
- Fundamental
- Price
- SBR $74.24
- LENZ $38.63
- Analyst Decision
- SBR
- LENZ Strong Buy
- Analyst Count
- SBR 0
- LENZ 4
- Target Price
- SBR N/A
- LENZ $49.75
- AVG Volume (30 Days)
- SBR 45.0K
- LENZ 713.8K
- Earning Date
- SBR 01-01-0001
- LENZ 07-30-2025
- Dividend Yield
- SBR 7.38%
- LENZ N/A
- EPS Growth
- SBR N/A
- LENZ N/A
- EPS
- SBR 5.05
- LENZ N/A
- Revenue
- SBR $77,682,730.00
- LENZ $5,000,000.00
- Revenue This Year
- SBR N/A
- LENZ N/A
- Revenue Next Year
- SBR N/A
- LENZ $258.37
- P/E Ratio
- SBR $14.64
- LENZ N/A
- Revenue Growth
- SBR N/A
- LENZ N/A
- 52 Week Low
- SBR $58.25
- LENZ $16.54
- 52 Week High
- SBR $74.57
- LENZ $41.70
- Technical
- Relative Strength Index (RSI)
- SBR 70.45
- LENZ 57.54
- Support Level
- SBR $71.30
- LENZ $36.81
- Resistance Level
- SBR $72.95
- LENZ $41.26
- Average True Range (ATR)
- SBR 1.58
- LENZ 2.50
- MACD
- SBR 0.16
- LENZ -0.12
- Stochastic Oscillator
- SBR 100.00
- LENZ 54.99
About SBR Sabine Royalty Trust
Sabine Royalty Trust is an express trust which is formed to receive Sabine Corporation's royalty and mineral interests, including landowner's royalties, overriding royalty interests, minerals production payments and any other similar, non-participatory interests, in certain Royalty Properties. The trusts producing and proved undeveloped oil and gas royalty properties are located in Florida, Louisiana, Mississippi, New Mexico, Oklahoma, and Texas.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.